Chandler Park: Informative talk by Hiba Khan on the PARP inhibitor combination trials
Chandler Park shared a post on X:
“Loved this informative talk by Dr. Hiba Khan, Fred Hutchinson Cancer Center. Updated table on the PARP inhibitor combination trials . Also a very thoughtful discussion for treatment escalation candidates for non-metastatic prostate cancer.”
Source: Chandler Park/X
More posts featuring Chandler Park on oncodaily.com
Chandler Park, MD, FACP is an haematologist oncologist, medical journalist, and clinical researcher. He is the Advisory Dean and Clinical Professor at University of Louisville School of Medicine. He is the Kentucky Physician Representative of the ASCO State Executive Council. He is also the Medical Oncology Board Examiner at American Board of Internal Medicine.
Hiba Khan, MD, MPH, is a physician at Fred Hutch and an Assistant Professor in both the Clinical Research Division at Fred Hutch and the Division of Hematology and Oncology at the University of Washington. She specializes in the treatment of cancers affecting the urinary and reproductive systems.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023